Marty Kelly

Marty Kelly is a nurse whose limited but consequential appearances trace a path through Somerset Medical Center’s handling of suspicious patient events: she contacted risk management about patients, sought a meeting after Reverend Gall died, and became the focus of an urgent call from New Jersey Poison Control. The account documents her place in the chain of communication, but leaves her knowledge and individual responsibility unresolved.

Position and Early Contacts

A timeline later submitted to the New Jersey Department of Health records that Kelly and pharmacist Nancy Doherty contacted risk manager Mary Lund on June 19 about the patients under scrutiny. The evidence establishes that Kelly was among the staff who brought the cases to Lund’s attention; it does not specify what she said, what conclusions she had reached, or what action she expected Lund to take.

Escalation After Reverend Gall’s Death

Reverend Gall died on Saturday, June 28. On Monday morning, Kelly asked to meet with Lund about the situation. Lund scheduled a meeting for the following day, bringing together senior medical, pharmacy, quality, and risk personnel. Among the measures considered afterward was a review of Pyxis access to digoxin in the Critical Care unit around the times of abnormal laboratory results, with particular attention to canceled drug orders and to Reverend Gall and Mrs. Han.

Kelly’s request marks a further escalation from the June 19 contact: by then, a patient had died, and concerns were moving into a broader institutional review. The account does not list Kelly among the meeting’s named participants or specify her role in the subsequent review, so her request should not be conflated with the decisions made by hospital leadership.

The Poison Control Call

Dr. Steven Marcus of New Jersey Poison Control later called Kelly and pressed her about the failure to call back concerning what he regarded as a life-or-death situation. In a separate call, Marcus reported the situation at Somerset to the New Jersey Department of Health and Senior Services. The account places Kelly within an increasingly strained exchange between Poison Control and the hospital, but does not give her side of the conversation or explain why a callback had not occurred.

A contemporaneous email records that Somerset’s risk manager, pharmacy director, chief operating officer, and chief medical officer said the hospital did not intend to notify the state health department or police until it had completed an internal investigation. Kelly is not identified among the people named in that email. The distinction matters: the record documents pressure directed at her over communication, while assigning the decision to delay reporting to other hospital officials.

Narrative Role and Limits

Kelly appears not as a fully developed personal portrait but as a point of contact in the unfolding institutional response. Her June 19 communication, post-death meeting request, and confrontation with Marcus show concern reaching risk management and Poison Control at different stages. Yet the evidence offers no account of her motives, her precise clinical role in the cases, or what she believed about their cause. Her significance lies in that documented position between warning and response—and in the limits of what the record allows readers to conclude about her.